Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Evidence Based Medicine presented by InpharmD™ · InpharmD™
September 26, 20208m 53s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
What does the evidence say on the safety and immunogenicity of the new Novavax vaccine for the SARS-CoV-2 infection?